---
figid: PMC3023199__zh10011161380004
figtitle: Dysregulated expression of fatty acid and cholesterol synthesis genes in
  liver is reversed by PPARG ligand treatments
organisms:
- Rattus norvegicus
- Homo sapiens
pmcid: PMC3023199
filename: zh10011161380004.jpg
figlink: /pmc/articles/PMC3023199/figure/F4/
number: F4
caption: 'Dysregulated expression of fatty acid and cholesterol synthesis genes in
  liver is reversed by PPARγ ligand treatments. A: Srebf1 expression. Data are averages
  normalized to LC group ± SE. *αbonf < 0.05 vs. FC group. B: red ovals, genes upregulated
  in FC vs. LC rats (involved in fatty acid synthesis). Green ovals, genes downregulated
  in FC vs. LC rats (involved in cholesterol synthesis). PPARγ ligand treatment reverses
  the FC group expression pattern, downregulating fatty acid synthesis genes (green-outlined
  ovals) and upregulating cholesterol synthesis genes (red-outlined ovals). Fill,
  differentially expressed in FC vs. LC groups; outline, differentially expressed
  in ≥1 PPARγ ligand-treated group compared with FC group. Asterisks above ovals indicate
  genes that exhibit ligand-selective expression (ANOVA, P < 0.05). Pathway adapted
  from Horton et al. ().'
papertitle: Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic
  pathways in obese rats.
reftext: Gene Hsiao, et al. Am J Physiol Endocrinol Metab. 2011 Jan;300(1):E164-E174.
year: '2011'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9028444
figid_alias: PMC3023199__F4
figtype: Figure
organisms_ner:
- Rattus norvegicus
- Homo sapiens
redirect_from: /figures/PMC3023199__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3023199__zh10011161380004.html
  '@type': Dataset
  description: 'Dysregulated expression of fatty acid and cholesterol synthesis genes
    in liver is reversed by PPARγ ligand treatments. A: Srebf1 expression. Data are
    averages normalized to LC group ± SE. *αbonf < 0.05 vs. FC group. B: red ovals,
    genes upregulated in FC vs. LC rats (involved in fatty acid synthesis). Green
    ovals, genes downregulated in FC vs. LC rats (involved in cholesterol synthesis).
    PPARγ ligand treatment reverses the FC group expression pattern, downregulating
    fatty acid synthesis genes (green-outlined ovals) and upregulating cholesterol
    synthesis genes (red-outlined ovals). Fill, differentially expressed in FC vs.
    LC groups; outline, differentially expressed in ≥1 PPARγ ligand-treated group
    compared with FC group. Asterisks above ovals indicate genes that exhibit ligand-selective
    expression (ANOVA, P < 0.05). Pathway adapted from Horton et al. ().'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Srebf1
  - Acaca
  - Nsmaf
  - Fas
  - Mvk
  - Pmvk
  - Por
  - Arfip2
  - Sqle
  - Lss
  - Acy1
  - Cyp51
  - Gpam
  - Dgat1
  - PKIA
  - PKIB
  - PKIG
  - POMC
  - SREBF1
  - ACAT1
  - CES1
  - SOAT1
  - ACACA
  - NSMAF
  - CNTRL
  - HMGCS1
  - FAS
  - FASN
  - DECR1
  - MVK
  - PMVK
  - TRAPPC2
  - POR
  - VDAC2
  - SQLE
  - LSS
  - LMBR1
  - ACY1
  - CYP51A1
  - GPAM
  - DGAT1
  - TMED7
  - LINC01194
  - Acetoacetyl CoA
  - Cholesterol
  - Glucose
  - Malonyl-CoA
  - Mevalonate
  - phosphate
  - Phosphoenolpyruvate
  - Pyruvate
  - Squalene
---
